Product Details
Product Name:
MitoPQ |
CAS No.:
1821370-28-8 |
Purity:
≥98% |
Supply Ability:
10g |
Release date:
2024/11/12 |
Product Introduction
Bioactivity
名稱 | MitoPQ |
描述 | MitoPQ (MitoParaquat) is a mitochondria-targeted small molecule compound that selectively enhances mitochondrial superoxide and hydrogen peroxide levels and inhibits insulin-stimulated glucose uptake and translocation of glucose transport protein 4 (GLUT4) to the plasma membrane in adipocytes and myotubes.MitoPQ can be used to MitoPQ can be used to study mitochondrial oxidative stress and regulated GLUT4 transporter. |
存儲條件 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 60 mg/mL (62.86 mM), Sonication is recommended. H2O : 20 mg/mL (20.95 mM), Sonication is recommended.
|
相關(guān)產(chǎn)品 | MSNBA | LDN-212320 | ML251 | Jujuboside A | Oxfendazole | SLC26A3-IN-1 | AZ PFKFB3 26 | BAY-876 | Phloretin | Dorzagliatin | Telaglenastat | PF-04937319 |
相關(guān)庫 | 經(jīng)典已知活性庫 | 激酶抑制劑庫 | 已知活性化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:139756-21-1
$46.00 / 500mg
-
CAS:80221-58-5
$41.00 / 1mg
-
CAS:531-44-2
$70.00 / 1mL
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |